Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

chemoradiotherapy

  • You have access
    18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer
    Antonio Avallone, Luigi Aloj, Biagio Pecori, Corradina Caracò, Alfonso De Stefano, Fabiana Tatangelo, Lucrezia Silvestro, Vincenza Granata, Francesco Bianco, Carmela Romano, Francesca Di Gennaro, Alfredo Budillon, Antonella Petrillo, Paolo Muto, Gerardo Botti, Paolo Delrio and Secondo Lastoria
    Journal of Nuclear Medicine November 1, 2019, 60 (11) 1560-1568; DOI: https://doi.org/10.2967/jnumed.118.222604
  • You have access
    18F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma
    Mian Xi, Zhongxing Liao, Wayne L. Hofstetter, Ritsuko Komaki, Linus Ho and Steven H. Lin
    Journal of Nuclear Medicine November 1, 2017, 58 (11) 1756-1763; DOI: https://doi.org/10.2967/jnumed.117.192591
  • You have access
    Role of 18F-FDG PET/CT in Posttreatment Evaluation of Anal Carcinoma
    Clémence Houard, Jean-Baptiste Pinaquy, Charles Mesguich, Bénédicte Henriques de Figueiredo, Anne-Laure Cazeau, Jean-Baptiste Allard, Hortense Laharie, Laurence Bordenave, Philippe Fernandez and Véronique Vendrely
    Journal of Nuclear Medicine September 1, 2017, 58 (9) 1414-1420; DOI: https://doi.org/10.2967/jnumed.116.185280
  • You have access
    Pretreatment 18F-FDG PET Textural Features in Locally Advanced Non–Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235
    Nitin Ohri, Fenghai Duan, Bradley S. Snyder, Bo Wei, Mitchell Machtay, Abass Alavi, Barry A. Siegel, Douglas W. Johnson, Jeffrey D. Bradley, Albert DeNittis, Maria Werner-Wasik and Issam El Naqa
    Journal of Nuclear Medicine June 1, 2016, 57 (6) 842-848; DOI: https://doi.org/10.2967/jnumed.115.166934
  • You have access
    Can an 18F-ALF-NOTA-PRGD2 PET/CT Scan Predict Treatment Sensitivity to Concurrent Chemoradiotherapy in Patients with Newly Diagnosed Glioblastoma?
    Hui Zhang, Ning Liu, Song Gao, Xudong Hu, Wei Zhao, Rongjie Tao, Zhaoqiu Chen, Jinsong Zheng, Xiaorong Sun, Liang Xu, Wanhu Li, Jinming Yu and Shuanghu Yuan
    Journal of Nuclear Medicine April 1, 2016, 57 (4) 524-529; DOI: https://doi.org/10.2967/jnumed.115.165514
  • You have access
    Are Pretreatment 18F-FDG PET Tumor Textural Features in Non–Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy?
    Gary J.R. Cook, Connie Yip, Muhammad Siddique, Vicky Goh, Sugama Chicklore, Arunabha Roy, Paul Marsden, Shahreen Ahmad and David Landau
    Journal of Nuclear Medicine January 1, 2013, 54 (1) 19-26; DOI: https://doi.org/10.2967/jnumed.112.107375
  • You have access
    Usefulness of 3′-Deoxy-3′-18F-Fluorothymidine PET for Predicting Early Response to Chemoradiotherapy in Head and Neck Cancer
    Takehito Kishino, Hiroshi Hoshikawa, Yoshihiro Nishiyama, Yuka Yamamoto and Nozomu Mori
    Journal of Nuclear Medicine October 1, 2012, 53 (10) 1521-1527; DOI: https://doi.org/10.2967/jnumed.111.099200
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire